Transgene (DuckCelt) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Transgene (DuckCelt) General Information
Description
An avian cell line grown in suspension. The cell line is permissive to a variety of viruses, including Influenza viruses and human Metapneumoviruses.
Contact Information
Corporate Office
- 400 Boulevard Gonthier d'Andernach
- Parc d'Innovation
- 67405 Illkirch-Graffenstaden
- France
Corporate Office
- 400 Boulevard Gonthier d'Andernach
- Parc d'Innovation
- 67405 Illkirch-Graffenstaden
- France
Transgene (DuckCelt) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Transgene (DuckCelt) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Transgene (DuckCelt) FAQs
-
Where is Transgene (DuckCelt) headquartered?
Transgene (DuckCelt) is headquartered in Illkirch-Graffenstaden, France.
-
What industry is Transgene (DuckCelt) in?
Transgene (DuckCelt)’s primary industry is Buildings and Property.
-
Is Transgene (DuckCelt) a private or public company?
Transgene (DuckCelt) is a Private company.
-
What is Transgene (DuckCelt)’s current revenue?
The current revenue for Transgene (DuckCelt) is
. -
Who are Transgene (DuckCelt)’s investors?
Transgene has invested in Transgene (DuckCelt).
-
When was Transgene (DuckCelt) acquired?
Transgene (DuckCelt) was acquired on 04-May-2020.
-
Who acquired Transgene (DuckCelt)?
Transgene (DuckCelt) was acquired by Vaxxel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »